Anasetti, C <br/><br/>
A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease.  [electronic resource] 

 -  Transplantation  Jul 1990 
 - 49-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-199007000-00010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Bone Marrow Transplantation<br/>Child, Preschool<br/>Female<br/>Graft vs Host Disease--therapy<br/>Humans<br/>Leukocyte Count<br/>Lymphocytes--immunology<br/>Male<br/>Mice<br/>Middle Aged<br/>Receptors, Interleukin-2--immunology